Aishwarya Kundu

Title: Aishwarya Kundu: Innovator in Prostate Cancer Treatment

Introduction

Aishwarya Kundu is a notable inventor based in Emeryville, CA (US). He has made significant contributions to the field of cancer treatment, particularly focusing on prostate cancer. His innovative approach has the potential to change the way this disease is treated.

Latest Patents

Aishwarya Kundu holds a patent for the invention titled "Intratumoral administration of sirolimus for treatment of prostate cancer." This patent describes methods of treating prostate cancer by administering an effective amount of sirolimus locally to the prostate of a subject in need thereof. The methods involve intratumoral injection of a liquid formulation comprising sirolimus, with dosages that exceed those typically used for preventing transplant rejection. He has 1 patent to his name.

Career Highlights

Aishwarya Kundu is currently associated with Santen Pharmaceutical Co., Ltd., where he continues to work on innovative solutions in the medical field. His research and development efforts are aimed at improving treatment options for patients suffering from prostate cancer.

Collaborations

Some of his coworkers include Sreenivasu Mudumba and Cecile Escudero, who contribute to the collaborative environment at Santen Pharmaceutical Co., Ltd. Their combined expertise fosters innovation and progress in cancer treatment.

Conclusion

Aishwarya Kundu's work in the field of prostate cancer treatment exemplifies the impact of innovative thinking in medicine. His patent on the intratumoral administration of sirolimus showcases his commitment to advancing healthcare solutions.